. Author manuscript; available in PMC: 2017 Jul 18.

Published in final edited form as: Cancer Immunol Immunother. 2011 Jan 26;60(5):629–638. doi: 10.1007/s00262-011-0970-1

Table 1.

Physical properties of the vaccine formulations

Formulation	Particle size (nm)^*	Zeta potential (mV)^**	Encapsulation efficiency (%)^***
R-DOTAP/E7	126.8 ± 5.1	54.3 ± 4.0	31.3 ± 16.6
S-DOTAP/E7	125.6 ± 7.8	55.8 ± 1.9	32.1 ± 8.9

Lipid concentration used in these studies was 6 mM, equivalent to 300 nmol of lipid per mouse

P = 0.69, n = 8–10

^**

P = 0.37, n = 8–10

^***

P = 0.87, n = 13–14